4.3 Article

US clinicians' perspectives on how mifepristone regulations affect access to medication abortion and early pregnancy loss care in primary care

Related references

Note: Only part of the references are listed.
Article Obstetrics & Gynecology

Mifepristone restrictions and primary care: Breaking the cycle of stigma through a learning collaborative model in the United States

Danielle Calloway et al.

Summary: Despite its safety record, mifepristone is subject to a highly restrictive set of regulatory measures through the REMS, reflecting and perpetuating a cycle of abortion stigma. The ExPAND Mifepristone learning collaborative targets institutional anxiety and logistical barriers to increase providers' self-efficacy. Learning collaboratives show promise in addressing the practical and psychological barriers to mifepristone use until the REMS is fully repealed.

CONTRACEPTION (2021)

Article Public, Environmental & Occupational Health

Barriers and Enablers to Family Physicians' Provision of Early Pregnancy Loss Management in the United States

Gabrielle deFiebre et al.

Summary: The study found that most surveyed family physicians provided expectant management of EPL. Survey results showed that some physicians provided medication management, while a small number provided manual vacuum aspiration. After conducting bivariate analyses, factors such as providing prenatal care, offering abortion care, access to ultrasound, and competency were positively associated with providing EPL management options.

WOMENS HEALTH ISSUES (2021)

Article Obstetrics & Gynecology

Induced Abortion Provision Among a National Sample of Obstetrician-Gynecologists

Daniel Grossman et al.

OBSTETRICS AND GYNECOLOGY (2019)

Editorial Material Medicine, General & Internal

Time to Reevaluate US Mifepristone Restrictions

Jane E. Henney et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Obstetrics & Gynecology

Patient Experiences With Miscarriage Management in the Emergency and Ambulatory Settings

Carolyn A. Miller et al.

OBSTETRICS AND GYNECOLOGY (2019)

Article Public, Environmental & Occupational Health

Trends in Risk of Pregnancy Loss Among US Women, 1990-2011

Lauren M. Rossen et al.

PAEDIATRIC AND PERINATAL EPIDEMIOLOGY (2018)

Article Medicine, General & Internal

Mifepristone Pretreatment for the Medical Management of Early Pregnancy Loss

Courtney A. Schreiber et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Obstetrics & Gynecology

Early Pregnancy Loss

Sarah Prager et al.

OBSTETRICS AND GYNECOLOGY (2018)

Article Public, Environmental & Occupational Health

Population Group Abortion Rates and Lifetime Incidence of Abortion: United States, 2008-2014

Rachel K. Jones et al.

AMERICAN JOURNAL OF PUBLIC HEALTH (2017)

Article Demography

Barriers to Abortion Care and Their Consequences For Patients Traveling for Services: Qualitative Findings from Two States

Jenna Jerman et al.

PERSPECTIVES ON SEXUAL AND REPRODUCTIVE HEALTH (2017)

Article Public, Environmental & Occupational Health

Impact of Clinic Closures on Women Obtaining Abortion Services After Implementation of a Restrictive Law in Texas

Caitlin Gerdts et al.

AMERICAN JOURNAL OF PUBLIC HEALTH (2016)

Article Demography

Barriers to and Facilitators of Moving Miscarriage Management Out of the Operating Room

Amanda Dennis et al.

PERSPECTIVES ON SEXUAL AND REPRODUCTIVE HEALTH (2015)

Article Public, Environmental & Occupational Health

Disparities in Abortion Rates: A Public Health Approach

Christine Dehlendorf et al.

AMERICAN JOURNAL OF PUBLIC HEALTH (2013)

Review Obstetrics & Gynecology

First-trimester medical abortion with mifepristone 200 mg and misoprostol: a systematic review

Elizabeth G. Raymond et al.

CONTRACEPTION (2013)